BioMed Partners raises SFr100m

BioMed Partners has held a final close for BioMedInvest III at SFr100 million ($106m; €87m), despite the firm missing its original target by SFr50 million. The healthcare venture capital fund seeks opportunities in Switzerland and Germany, as well as their neighbouring European countries. The vehicle will make investments in 12 to 15 companies per year.

The capital base is made up of new and existing investors, including the European Investment Fund and the Berner Kantonalbank.